Daniel J. Starck's most recent trade in Owens & Minor, Inc. was a trade of 9,446 Common Stock done at an average price of $19.8 . Disclosure was reported to the exchange on May 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Owens & Minor, Inc. | Daniel J. Starck | EVP, Business Excellence | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.78 per share. | 15 May 2024 | 9,446 | 95,612 (0%) | 0% | 19.8 | 186,842 | Common Stock |
| Owens & Minor, Inc. | Daniel J. Starck | EVP, Business Excellence | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 32,975 | 105,058 (0%) | 0% | 0 | Common Stock | |
| Owens & Minor, Inc. | Daniel J. Starck | EVP, Business Excellence | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.73 per share. | 15 May 2023 | 2,139 | 72,083 (0%) | 0% | 18.7 | 40,063 | Common Stock |
| Owens & Minor, Inc. | Daniel J. Starck | EVP, Business Excellence | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 52,624 | 74,222 (0%) | 0% | 0 | Common Stock | |
| Owens & Minor, Inc. | Daniel J. Starck | EVP, President Patient Direct, & CEO of Apria | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 21,598 | 21,598 (0%) | 0% | 0 | Common Stock |